Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Nat Commun ; 6: 8303, 2015 Sep 18.
Article in English | MEDLINE | ID: mdl-26383514

ABSTRACT

Cell-cell interactions promote juxtacrine signals in specific subcellular domains, which are difficult to capture in the complexity of the nervous system. For example, contact between axons and Schwann cells triggers signals required for radial sorting and myelination. Failure in this interaction causes dysmyelination and axonal degeneration. Despite its importance, few molecules at the axo-glial surface are known. To identify novel molecules in axo-glial interactions, we modified the 'pseudopodia' sub-fractionation system and isolated the projections that glia extend when they receive juxtacrine signals from axons. By proteomics we identified the signalling networks present at the glial-leading edge, and novel proteins, including members of the Prohibitin family. Glial-specific deletion of Prohibitin-2 in mice impairs axo-glial interactions and myelination. We thus validate a novel method to model morphogenesis and juxtacrine signalling, provide insights into the molecular organization of the axo-glial contact, and identify a novel class of molecules in myelination.


Subject(s)
Axons/metabolism , Myelin Sheath/metabolism , Paracrine Communication , Pseudopodia/metabolism , Repressor Proteins/metabolism , Schwann Cells/metabolism , Animals , Blotting, Western , Fluorescent Antibody Technique , Ganglia, Spinal/cytology , Immunohistochemistry , Mice , NIH 3T3 Cells , Neuroglia/metabolism , Prohibitins , Proteomics , Rats
2.
AJNR Am J Neuroradiol ; 35(10): 1916-23, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24874536

ABSTRACT

BACKGROUND AND PURPOSE: Identifying MRI biomarkers that can differentiate multiple sclerosis patients from other neurological disorders is a subject of intense research. Our aim was to investigate phase WM signal abnormalities for their presence, prevalence, location, and diagnostic value among patients with clinically isolated syndrome and other neurologic disorders and age-, sex-, and group-matched healthy controls. MATERIALS AND METHODS: Forty-eight patients with clinically isolated syndrome and 30 patients with other neurologic diseases and a healthy control group (n = 47) were included in the study. Subjects were scanned at 3T by using SWI-filtered phase and T2WI, with WM signal abnormalities ≥3 mm being classified. RESULTS: Patients with clinically isolated syndrome had significantly more phase and T2 WM signal abnormalities than healthy controls (P < .001). Phase WM signal abnormalities were more prevalent among patients with clinically isolated syndrome compared with patients with other neurologic disorders (4:1 ratio), whereas T2 WM signal abnormalities were more ubiquitous with a 2:1 ratio. The presence of phase WM signal abnormalities was sensitive for clinically isolated syndrome (70.8%) and achieved a moderate-to-high specificity for differentiating patients with clinically isolated syndrome and healthy controls, patients with other neurologic disorders, and patients with other neurologic disorders of other autoimmune origin (specificity, 70%-76.7%). Combining the presence of ≥2 phase lesions with the McDonald 2005 and 2010 criteria for dissemination in space improved the specificity (90%), but not the accuracy, in differentiating patients with clinically isolated syndrome from those with other neurologic disorders. In subanalyses among patients with clinically isolated syndrome who converted to clinically definite multiple sclerosis versus those who did not within a 3-year follow-up period, converters had significantly more phase (P = .008) but not T2 or T1 WM signal abnormalities. CONCLUSIONS: Phase WM signal abnormalities are prevalent among patients with clinically isolated syndrome. The presence of (multiple) phase WM signal abnormalities tended to be more predictive of conversion to clinically definite multiple sclerosis and was specific in differentiating patients with clinically isolated syndrome and other neurologic disorders, compared with T2 WM signal abnormalities; however, the accuracy remains similar to that of the current McDonald criteria.


Subject(s)
Demyelinating Diseases/diagnosis , Magnetic Resonance Imaging/methods , White Matter/pathology , Adult , Aged , Female , Follow-Up Studies , Humans , Leukoaraiosis/diagnosis , Male , Middle Aged , Multiple Sclerosis/diagnosis , Prevalence , Sensitivity and Specificity
3.
J Environ Qual ; 41(2): 544-53, 2012.
Article in English | MEDLINE | ID: mdl-22370417

ABSTRACT

Modeling is a common practice to evaluate factors affecting water quality in environmental systems impaired by point and nonpoint losses of N and P. Nevertheless, in situations with inadequate information, such as ungauged basins, a balance between model complexity and data availability is necessary. In this paper, we applied a simplified analytical model to an artificially drained floodplain in central-western Italy to evaluate the importance of different nutrient sources and in-stream retention processes and to identify critical source areas. We first considered only a set of chemical concentrations in water measured from February through May 2008 and from November 2008 through February 2009. We then broadened available data to include water discharge and hydraulic-head measurements to construct a hydrogeological model using MODFLOW-2000 and to evaluate the reliability of the simplified method. The simplified model provided acceptable estimates of discharge (ranging from 0.03-0.75 m s) and diffuse nutrient inputs from water table discharge and in-stream retention phenomena. Estimates of PO-P and total P retention (ranging from 1.0 to 0.6 µg m s and from 1.18 to 0.95 µg m s for PO-P and total P, respectively) were consistent with the range of variability in literature data. In contrast, the higher temporal variability of nitrate concentrations decreased model accuracy, suggesting the need for more intensive monitoring. The model also separated the dynamics of different reaches of the drainage network and identified zones considered critical source areas and buffer zones where pollutant transport is reduced.


Subject(s)
Lakes/chemistry , Models, Theoretical , Nitrogen/analysis , Phosphorus/analysis , Water Pollutants, Chemical/analysis , Water/chemistry , Diffusion , Italy , Nitrates/analysis , Nitrates/chemistry , Nitrogen/chemistry , Phosphorus/chemistry , Water Pollutants, Chemical/chemistry
4.
Minerva Cardioangiol ; 56(1): 13-20, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18432164

ABSTRACT

AIM: The aim of this study was to evaluate the effect of insulin-like growth factor 1 (IGF1) and transforming growth factor beta-1 (TGFbeta-1) on collagen turnover, left ventricular (LV) hypertrophy and on passive diastolic function of the LV in hypertrophic cardiomyopathy (HCM). METHODS: This study group comprised 34 patients with non-dilated HCM. Procollagen I amino-terminal propeptide (PINP) and collagen I carboxy-terminal telopeptide (ICTP) were measured by radioimmunoassay. Matrix metalloproteinase 9 (MMP 9), IGF1 and TGFalfa-1 were determined by enzyme-linked immunosorbent assay. The difference in duration between transmitral forward (A) and pulmonary venous retrograde (Ar) waves, was considered as an estimate of passive diastolic function; the ratio between the peak flow velocity at rapid filling at the mitral level (E) and E' measured by tissue Doppler was considered an estimate of active diastolic function. LV mass was measured and normalized to body surface area (LVMi) by cardiac magnetic resonance imaging. RESULTS: LVMi correlates to E/E' (r=0.597, P=0.019 ) and is inversely related to A-Ar (r=0.453, P=0.015). TGFbeta-1 is directly related to active MMP 9 (r=0.439, P=0.012 ). IGF1 is directly related to PICP-ICTP (r=0.347, P=0.501), that expresses the balance between collagen I synthesis and its degradation. CONCLUSION: The study demonstrated that in HCM, LVMi influences active and passive diastolic dysfunction and that IGF1 stimulates collagen synthesis and TGFbeta-1 is related to LV hypertrophy.


Subject(s)
Cardiomyopathy, Hypertrophic/diagnosis , Cardiomyopathy, Hypertrophic/metabolism , Collagen/metabolism , Hypertrophy, Left Ventricular/diagnosis , Hypertrophy, Left Ventricular/metabolism , Insulin-Like Growth Factor I/metabolism , Transforming Growth Factor beta1/metabolism , Adult , Algorithms , Biomarkers/metabolism , Collagen Type I , Echocardiography, Doppler , Enzyme-Linked Immunosorbent Assay , Female , Humans , Magnetic Resonance Imaging , Male , Matrix Metalloproteinase 9/metabolism , Middle Aged , Myocardium/metabolism , Peptide Fragments/metabolism , Peptides , Procollagen/metabolism , Radioimmunoassay , Ventricular Dysfunction, Left/diagnosis , Ventricular Dysfunction, Left/metabolism
5.
G Ital Nefrol ; 24 Suppl 40: s37-41, 2007.
Article in Italian | MEDLINE | ID: mdl-18034410

ABSTRACT

Medicine is an outstanding example of an empirical science in theory and practice. In every stage of his work a doctor should be ready to pick up signs of possible scientific progress. Being constantly attentive and able to see anything new occurring, however difficult it may be to discern, should remain the basis of any professional commitment that takes care not to become sterile and thereby less effective in treating disease. A doctor is an experimenter par excellence, one who constantly applies experimental methods based on his own ''historical'' knowledge, experience, and capacity to comprehend even the tiniest signals that reach him from the real world. On the other hand, although the indiscriminate acceptance of results obtained by clinical trials and the increasing recourse to technology could herald the end of clinical freedom, we believe that such recourse to technology is, in fact, desirable. The reason for this belief is that a lack of innovation leads to loss of enthusiasm and loss of interest in specific clinical problems; it also results in a cultural attitude that refutes the notion of experimental logic being inherent in any treatment because of the changeability of individual conditions on a biological, clinical, and psycho-relational level.


Subject(s)
Clinical Medicine , Physicians
SELECTION OF CITATIONS
SEARCH DETAIL
...